VHL 7.69% 14.0¢ virax holdings limited

Previous trials with TCN-P, page-13

  1. 366 Posts.
    Even that late 2013 publication ends with "Further investigation of TCN-PM alone or in combination in patients with high Akt levels is warranted", VHL are doing that.
 
watchlist Created with Sketch. Add VHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.